---
title: Self managed exercise improves walking
nct_id: NCT07302386
phase: NA
status: RECRUITING
sponsor: Marmara University
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07302386"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07302386"
last_fetched: "2026-05-10T14:02:17.116Z"
source: "Parkinson's Pathways (curated)"
---
# Self managed exercise improves walking

**Goal (in five words):** Self managed exercise improves walking

**Official Title:** The Effects of Exercise Management in Parkinson's Disease

**Trial ID:** [NCT07302386](https://clinicaltrials.gov/study/NCT07302386)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Marmara University
- **Target Enrollment:** 30 participants
- **Start Date:** 2025-12-15
- **Completion Date:** 2026-11-07
- **Conditions:** Parkinson Disease (PD)
- **Interventions:** Telerehabilitation
- **Intervention Types:** OTHER

## Summary For Families

The trial aims to see whether a structured exercise program delivered remotely can improve walking, balance, and everyday mobility for people with mild-to-moderate Parkinson's. Participants do telerehabilitation sessions guided by therapists over video or an app, using targeted strength, balance, and movement exercises that help muscle function and motor control and support brain plasticity; this approach is meant to complement medications like levodopa, not replace them. They are enrolling people age 45 to 80 with idiopathic Parkinson's at Hoehn and Yahr stage I to III, MoCA 21 or higher, able to walk 100 meters and use basic technology, and not on deep brain stimulation or living with other major neurologic, cardiopulmonary, musculoskeletal, vision, or hearing problems.

## Eligibility

- **Minimum age:** 45 Years
- **Maximum age:** 80 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Diagnosed with Idiopathic Parkinson's Disease by a neurologist according to the UK Parkinson's Disease Association Brain Bank clinical diagnostic criteria
* H\&Y Stage I-III
* Montreal Cognitive Assessment Scale MoCA≥21
* Having the necessary technological devices to participate in telerehabilitation
* Being able to walk 100 meters
* Having at least a primary school diploma

Exclusion Criteria:

* Presence of a neurological disorder other than Parkinson's disease
* Presence of any cardiopulmonary or musculoskeletal problem that affects gait and balance
* Receiving Deep Brain Stimulation (DBS) treatment or having undergone DBS surgery in the past
* Presence of vision or hearing problems
```

## Locations (1)

- Marmara University, Maltepe, Istanbul, Turkey (Türkiye) _(40.9357, 29.1551)_
  - Gökçe Kartal — (CONTACT) — 05055624837 — gokcekartal95@hotmail.com

## Central Contacts

- Gökçe Kartal — (CONTACT) — +905055624837 — gokcekrtl2@gmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT07302386*  
*HTML version: https://parkinsonspathways.com/trial/NCT07302386*  
*Source data: https://clinicaltrials.gov/study/NCT07302386*